Tracheal tube

Hydromer as the Exclusive Coatings Partner for N8 Announces the CeraShield Coating Has Demonstrated the Ability to Inhibit and Reduce the Growth of COVID-19 Virus on Tube Surfaces

Retrieved on: 
Tuesday, August 18, 2020
Health, Zoonoses, Articles, Medical equipment, Medicine, Tracheal tube, Coronavirus disease, Virus, Health, Zoonoses, Articles, Medical equipment, Medicine, Tracheal tube, Coronavirus disease, Virus

Concord, NC, Aug. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hydromer Incorporated (OTC:HYDI) or the Company announced today, as the exclusive coatings supplier and manufacturing partner for N8 Medicals CeraShield coated endotracheal tubes, that the CeraShield coating has in recent testing demonstrated the ability to inhibit and reduce the growth of COVID-19 virus on tube surfaces.

Key Points: 
  • Concord, NC, Aug. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hydromer Incorporated (OTC:HYDI) or the Company announced today, as the exclusive coatings supplier and manufacturing partner for N8 Medicals CeraShield coated endotracheal tubes, that the CeraShield coating has in recent testing demonstrated the ability to inhibit and reduce the growth of COVID-19 virus on tube surfaces.
  • The testing showed statistically significant reduction in the growth of COVID-19 virus on the tube surface in 60 minutes.
  • Ordinary uncoated endotracheal tubes either allowed increased virus growth or had no inhibitory effect.
  • CAUTION: In United States, the CeraShield Endotracheal Tube has not been granted marketing approval.

Health Canada provides COVID-19 Interim Order approval for Bactiguard's endotracheal tubes

Retrieved on: 
Wednesday, August 12, 2020
Medicine, Clinical medicine, Medical specialties, Medical equipment, Respiratory therapy, Intensive care medicine, Anesthesia, Otorhinolaryngology, Tracheal intubation, Tracheal tube, Mechanical ventilation, Coronavirus disease

STOCKHOLM, Aug. 12, 2020 /PRNewswire/ -- Health Canada has approved Bactiguard's endotracheal tubes for infection prevention through an Interim Order.

Key Points: 
  • STOCKHOLM, Aug. 12, 2020 /PRNewswire/ -- Health Canada has approved Bactiguard's endotracheal tubes for infection prevention through an Interim Order.
  • The approval is driven by COVID-19, as Bactiguard's endotracheal tubes can reduce the risk of secondary infections for critically ill patients.
  • "Many critically ill COVID-19 patients require intubation with an endotracheal tube (ETT) and mechanical ventilation.
  • Our Health Canada licences include DEL, MDEL, and NHP to import, wholesale and distribute drug and medical devices as well as the ability to package and re-label them.

Health Canada provides COVID-19 Interim Order approval for Bactiguard's endotracheal tubes

Retrieved on: 
Wednesday, August 12, 2020
Medicine, Clinical medicine, Medical specialties, Medical equipment, Respiratory therapy, Intensive care medicine, Anesthesia, Otorhinolaryngology, Tracheal intubation, Tracheal tube, Mechanical ventilation, Coronavirus disease

STOCKHOLM, Aug. 12, 2020 /PRNewswire/ -- Health Canada has approved Bactiguard's endotracheal tubes for infection prevention through an Interim Order.

Key Points: 
  • STOCKHOLM, Aug. 12, 2020 /PRNewswire/ -- Health Canada has approved Bactiguard's endotracheal tubes for infection prevention through an Interim Order.
  • The approval is driven by COVID-19, as Bactiguard's endotracheal tubes can reduce the risk of secondary infections for critically ill patients.
  • "Many critically ill COVID-19 patients require intubation with an endotracheal tube (ETT) and mechanical ventilation.
  • Our Health Canada licences include DEL, MDEL, and NHP to import, wholesale and distribute drug and medical devices as well as the ability to package and re-label them.

Endotracheal Tubes Market Size Worth $2.9 Billion by 2027: Grand View Research, Inc.

Retrieved on: 
Wednesday, June 24, 2020
Medicine, Clinical medicine, Medical specialties, Medical equipment, Tracheal tube, Tracheal intubation, Compound annual growth rate

SAN FRANCISCO, June 24, 2020 /PRNewswire/ -- The global endotracheal tubes market size is expected to reach USD 2.9 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, June 24, 2020 /PRNewswire/ -- The global endotracheal tubes market size is expected to reach USD 2.9 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc.
  • The rising prevalence of chronic diseases such as respiratory, cardiovascular diseases, and increasing number of surgical procedures, are expected to propel market growth.
  • In addition, technological development in the medical device is further expected to contribute to market growth during forecast period.
  • Grand View Research has segmented the global endotracheal tubes market based on product type, route type, application, end use, and region:
    Endotracheal Tubes Product Type Outlook (Revenue, USD Million, 2016 - 2027)

Endotracheal Tubes Market Size Worth $2.9 Billion by 2027: Grand View Research, Inc.

Retrieved on: 
Wednesday, June 24, 2020
Medicine, Clinical medicine, Medical specialties, Medical equipment, Tracheal tube, Tracheal intubation, Compound annual growth rate

SAN FRANCISCO, June 24, 2020 /PRNewswire/ -- The global endotracheal tubes market size is expected to reach USD 2.9 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, June 24, 2020 /PRNewswire/ -- The global endotracheal tubes market size is expected to reach USD 2.9 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc.
  • The rising prevalence of chronic diseases such as respiratory, cardiovascular diseases, and increasing number of surgical procedures, are expected to propel market growth.
  • In addition, technological development in the medical device is further expected to contribute to market growth during forecast period.
  • Grand View Research has segmented the global endotracheal tubes market based on product type, route type, application, end use, and region:
    Endotracheal Tubes Product Type Outlook (Revenue, USD Million, 2016 - 2027)

Hydromer and N8 Medical Partner to Bring Life-Saving Coated ET Tubes for COVID-19 Patients

Retrieved on: 
Friday, April 24, 2020
Medicine, Medical specialties, Clinical medicine, Medical equipment, Respiratory therapy, Anesthesia, Intensive care medicine, Tracheal tube, Tracheal intubation, Medical device, Biofouling

Health Canada has granted emergency use access marketing approval for the CeraShield Endotracheal Tube for all Canadian mechanically-ventilated COVID-19 patients.

Key Points: 
  • Health Canada has granted emergency use access marketing approval for the CeraShield Endotracheal Tube for all Canadian mechanically-ventilated COVID-19 patients.
  • N8's CeraShield tube has a patented anti-fouling coating to prevent deadly bacterial infections that frequently occur in ventilated patients.
  • N8 Medical, LLC (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.
  • If you have an interest in coating your devices or the CeraShield endotracheal tubes, please contact us right away!

Health Canada Grants Emergency Use Authorization for N8 Medical CeraShield™ Endotracheal Tubes in Mechanically Ventilated COVID-19 Patients

Retrieved on: 
Thursday, April 2, 2020
Medicine, Clinical medicine, Medical specialties, Medical equipment, Anesthesia, Respiratory therapy, Intensive care medicine, Otorhinolaryngology, Tracheal intubation, Tracheal tube

DUBLIN, Ohio, April 2, 2020 /PRNewswire/ --N8 Medical, LLC (N8 Medical) today announced that Health Canada has granted Dr. John Muscedere of Kingston General Hospital's emergency request to begin using the N8 Medical CeraShield Endotracheal Tubes in mechanically-ventilated COVID-19 patients.

Key Points: 
  • DUBLIN, Ohio, April 2, 2020 /PRNewswire/ --N8 Medical, LLC (N8 Medical) today announced that Health Canada has granted Dr. John Muscedere of Kingston General Hospital's emergency request to begin using the N8 Medical CeraShield Endotracheal Tubes in mechanically-ventilated COVID-19 patients.
  • N8 Medical's CeraShield Endotracheal Tube has a patented anti-fouling coating that is designed to prevent deadly bacterial infections that frequently occur in ventilated patients with respiratory viral infections.
  • N8 Medical believes that use of the CeraShield Endotracheal Tube may reduce this rate of mortality.
  • Dr. Muscedere was the Principal Investigator in a clinical feasibility study of the CeraShield Endotracheal Tube of ten patients at Kingston General who were intubated with the CeraShield Endotracheal Tube.

Global Endotracheal Tube Market to Surpass US$ 1,212.8 Million by 2027 - Coherent Market Insights

Retrieved on: 
Monday, March 9, 2020
Medical equipment, Tracheal tube, Compound annual growth rate, Tracheotomy, Academic disciplines, Health care, Articles

SEATTLE, March 9, 2020 /PRNewswire/ -- According to Coherent Market Insights, the global endotracheal tube market is estimated to be valued at US$ 739.4 million in 2019, and is expected to exhibit a CAGR of 6.4% over the forecast period (2019-2027).

Key Points: 
  • SEATTLE, March 9, 2020 /PRNewswire/ -- According to Coherent Market Insights, the global endotracheal tube market is estimated to be valued at US$ 739.4 million in 2019, and is expected to exhibit a CAGR of 6.4% over the forecast period (2019-2027).
  • The increasing product launches is expected to drive growth of the global endotracheal tube market over the forecast period.
  • For instance, in January 2020, Smiths Medical, a global medical devices manufacturing company launched Portex tracheostomy tubes and kits.
  • The global endotracheal tube market is expected to exhibit a CAGR of 6.4% over the forecast period, owing to rising incidence of respiratory and pulmonary disorders and increasing number of product launches.

Endotracheal Tubes, 2020 - Medical Devices Pipeline Assessment - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 26, 2020
Medical devices, Health, Medicine, Clinical medicine, Medical specialties, Medical equipment, Anesthesia, Intensive care medicine, Respiratory therapy, Tracheal tube, Tracheal intubation, Medtronic, Teleflex

Nov 14, 2019: Medtronic Highlights Leadership In Inclusion, Diversity, And Equity In 2019 Integrated Performance Report

Key Points: 
  • Nov 14, 2019: Medtronic Highlights Leadership In Inclusion, Diversity, And Equity In 2019 Integrated Performance Report
    Aug 02, 2019: Centurion Medical Products Recalls Airway Kit Containing Sheridan Endotracheal Tubes Due To Potential For The Tube Connector To Dislodge, Which May Result In Disconnection Of The Patient From The Breathing Circuit
    Feb 21, 2019: Teleflex Reports Fourth Quarter And Full Year 2018 Results; Provides 2019 Guidance